Conversations in Drug Development
Welcome to Conversations in Drug Development, brought to you by the team at Boyds for our fellow community of scientists and clinicians working in the wonderful world of cell and gene therapy and drug development. This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge science and drug development in the pharmaceutical and biotechnology sector.
Listen on:
Episodes
Monday Dec 04, 2023
Monday Dec 04, 2023
In this episode of "Conversations in Drug Development", Harriet Edwards and Dr. Patrick Ginty discuss off-the-shelf cell therapies, explaining how these therapies are manufactured and their ability to treat multiple recipients. While these therapies offer scalability and the potential to treat larger patient populations, they also carry risks such as immune reactions. Dr. Ginty highlights the importance of addressing these risks and mentions techniques like gene editing to improve safety. Join us in this conversation as we discuss the regulatory challenges in developing these therapies, emphasizing the importance of early engagement with regulators and compliance with donor testing requirements.
To discuss this episode of Conversations in Drug Development with a member of the team, visit www.boydconsultants.com.
Wednesday Nov 08, 2023
Wednesday Nov 08, 2023
In this episode of Conversations in Drug Development, Dr. Julie Warner and Harriet Edwards discuss the revolutionizing role of artificial intelligence (AI) in drug development, exploring its applications in data analysis and toxicity prediction, and its potential to reduce animal testing. Join us in this conversation, as we discuss the challenges of regulating AI in this rapidly evolving field and the need for collaboration between regulators and developers. Is AI pushing the boundaries of what's possible?
To discuss this episode of Conversations in Drug Development with a member of the team, visit www.boydconsultants.com.
Wednesday Oct 04, 2023
Wednesday Oct 04, 2023
In this episode, Dr Katherine Bowen and Dr Julie Warner delve deep into the ever-evolving world of oncology drug development and the regulatory landscape in the US and EU. Join us in this conversation, as we cover the key shifts in the field over the past few decades, regulatory challenges, FDA initiatives and future developments in oncology drug development, including the impact of AI, machine learning, and CRISPR technologies.
To discuss this episode of Conversations in Drug Development with a member of the team, visit www.boydconsultants.com
This podcast series features candid conversations from the expert team at Boyds, who are at the forefront of cutting-edge drug development in the pharmaceutical and biotechnology sector.
Our experts and special guests will share their stories, experiences, and expertise, offering a behind-the-scenes look at the cutting-edge research, clinical trials, regulatory hurdles, and numerous other factors that shape the drug development landscape. Whether you’re a healthcare professional, a patient, a researcher, or simply curious about the world of medicine, this podcast promises to expand your understanding of the complex journey from molecule to medicine.
Join us as we explore the dynamic and ever-evolving field of drug development, one conversation at a time.